Rapid Micro Biosystems, Inc. Class A Common Stock (RPID) is a publicly traded Healthcare sector company. As of September 20, 2026, RPID trades at $1.15 with a market cap of $56.18M and a P/E ratio of -1.04. RPID moved +3.67% today. Year to date, RPID is -61.38%; over the trailing twelve months it is -65.22%. Its 52-week range spans $1.09 to $4.94. Analyst consensus is buy with an average price target of $7.50. Rallies surfaces RPID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RPID, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.15 |
| Market Cap | $56.18M |
| P/E Ratio | -1.04 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.94 |
| 52-Week Low | $1.09 |
| Volume | 601.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $35.18M |
| Net Income | $-51.20M |
| Gross Margin | 0.00% |
2 analysts cover RPID: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.50.